These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Fas signaling in thyroid carcinomas is diverted from apoptosis to proliferation. Mitsiades CS; Poulaki V; Fanourakis G; Sozopoulos E; McMillin D; Wen Z; Voutsinas G; Tseleni-Balafouta S; Mitsiades N Clin Cancer Res; 2006 Jun; 12(12):3705-12. PubMed ID: 16778096 [TBL] [Abstract][Full Text] [Related]
10. Phosphatidylinositol 3-kinase/nuclear factor-kappa B signaling pathway is involved in the regulation of IGF-I on Fas-associated death domain-like interleukin-1-converting enzyme-inhibitory protein expression in cultured FRTL thyroid cells. Ren M; Guan Q; Zhong X; Gong B; Sun Y; Xin W; Guo J; Wang H; Gao L; Zhao J J Mol Endocrinol; 2007 Jun; 38(6):619-25. PubMed ID: 17556532 [TBL] [Abstract][Full Text] [Related]
11. Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: Relationship to Bcl-2 family and caspase activation. Hamaï A; Richon C; Meslin F; Faure F; Kauffmann A; Lecluse Y; Jalil A; Larue L; Avril MF; Chouaib S; Mehrpour M Oncogene; 2006 Dec; 25(58):7618-34. PubMed ID: 16983347 [TBL] [Abstract][Full Text] [Related]
12. B cell receptor cross-linking prevents Fas-induced cell death by inactivating the IL-1 beta-converting enzyme protease and regulating Bcl-2/Bcl-x expression. Brás A; Martinez-A C; Baixeras E J Immunol; 1997 Oct; 159(7):3168-77. PubMed ID: 9317114 [TBL] [Abstract][Full Text] [Related]
13. Bortezomib induces caspase-dependent apoptosis in Hodgkin lymphoma cell lines and is associated with reduced c-FLIP expression: a gene expression profiling study with implications for potential combination therapies. Zhao X; Qiu W; Kung J; Zhao X; Peng X; Yegappan M; Yen-Lieberman B; Hsi ED Leuk Res; 2008 Feb; 32(2):275-85. PubMed ID: 17659339 [TBL] [Abstract][Full Text] [Related]
14. Critical role for c-FLIP(L) on Fas resistance in colon carcinoma cell line HT-29. Zang F; Sun B; Zhao X; Niu R; Zhang S; Yu M; Wei X; Zhang L Cell Biol Int; 2008 Mar; 32(3):329-36. PubMed ID: 18243739 [TBL] [Abstract][Full Text] [Related]
15. Expression of the NF-kappaB targets BCL2 and BIRC5/Survivin characterizes small B-cell and aggressive B-cell lymphomas, respectively. Tracey L; Pérez-Rosado A; Artiga MJ; Camacho FI; Rodríguez A; Martínez N; Ruiz-Ballesteros E; Mollejo M; Martinez B; Cuadros M; Garcia JF; Lawler M; Piris MA J Pathol; 2005 Jun; 206(2):123-34. PubMed ID: 15880597 [TBL] [Abstract][Full Text] [Related]
16. FAS (CD95) mutations are rare in gastric MALT lymphoma but occur more frequently in primary gastric diffuse large B-cell lymphoma. Wohlfart S; Sebinger D; Gruber P; Buch J; Polgar D; Krupitza G; Rosner M; Hengstschläger M; Raderer M; Chott A; Müllauer L Am J Pathol; 2004 Mar; 164(3):1081-9. PubMed ID: 14982861 [TBL] [Abstract][Full Text] [Related]
17. The gene for interleukin-21 receptor is the partner of BCL6 in t(3;16)(q27;p11), which is recurrently observed in diffuse large B-cell lymphoma. Ueda C; Akasaka T; Kurata M; Maesako Y; Nishikori M; Ichinohasama R; Imada K; Uchiyama T; Ohno H Oncogene; 2002 Jan; 21(3):368-76. PubMed ID: 11821949 [TBL] [Abstract][Full Text] [Related]
18. Feedback regulation of mitochondria by caspase-9 in the B cell receptor-mediated apoptosis. Eeva J; Nuutinen U; Ropponen A; Mättö M; Eray M; Pellinen R; Wahlfors J; Pelkonen J Scand J Immunol; 2009 Dec; 70(6):574-83. PubMed ID: 19906200 [TBL] [Abstract][Full Text] [Related]
19. Acquisition of Fas resistance by Fas receptor mutation in a childhood B-precursor acute lymphoblastic leukemia cell line, MML-1. Inaba H; Shimada K; Zhou YW; Ido M; Buck S; Yonehara S; Kaplan J; Komada Y Int J Oncol; 2005 Aug; 27(2):573-9. PubMed ID: 16010441 [TBL] [Abstract][Full Text] [Related]
20. Expression of cellular FLICE inhibitory protein, caspase-8, and protease inhibitor-9 in Ewing sarcoma and implications for susceptibility to cytotoxic pathways. de Hooge AS; Berghuis D; Santos SJ; Mooiman E; Romeo S; Kummer JA; Egeler RM; van Tol MJ; Melief CJ; Hogendoorn PC; Lankester AC Clin Cancer Res; 2007 Jan; 13(1):206-14. PubMed ID: 17200356 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]